Replies to post #516764 on Anavex Life Sciences Corp (AVXL)

[BIOChecker4]

“As I recall people were calling for Dr. M to concentrate on Alzheimer’s rather than waste time with other indications.”

Nobody ever said any such thing. Plus there’s no reason two things (or even three) can’t be done at the same time.

Show us just one instance where anybody urged Missling to concentrate on Alzheimer’s rather than “waste time” with other indications. You can’t, because it never happened.

Stop defending this guy already and just own up to having been terribly wrong. He’s been a train wreck and destroyer of shareholder value (while making himself rich at shareholders’ expense).

[powerwalker]

pete, we were lead to believe that the OLE data and other new data assembled would be allowed to be presented in the re-exam process. That was not true and caused many, including me, to have false hopes. If they knew it would not be accepted, then Anavex should have waited.

The filing last year was a "Hail Mary" pass, not a strong data set that it was claimed to be. My impression is that both sets of CHMP reviewers did not believe the numbers. Why else would Missling's last ditch appeal of a 10mg of blarcamesine add-on not be accepted, when there is NO risk involved at that dose!!

As to the fda, we have had many statements over 10 years about conversations with it, but still NOTHING!

Most of the people here, including me, wants to see the voucher and would sign up to get Blarcamesine as quickly as possible. But the old adage, "I'll believe it when I see it," is still apropos here.